FridayJun 24, 2022 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Authorizes the Repurchase of up to $5 Million Shares

Flora Growth Corp. announced that the Company Board has authorized the repurchase of up to $5 million of its outstanding common shares Luis Merchan, Flora’s Chairman and CEO, said that Flora is executing its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses At the closing of 2021, the company announced a 2022 revenue guidance projection of $35-45 million Flora Growth (NASDAQ: FLGC) is a global leader in the cultivation, marketing, and distribution of premium-quality cannabis products and brands at below-market prices. Flora Growth recently announced that the company’s Board of Directors (the "Board") has authorized…

Continue Reading

ThursdayJun 23, 2022 1:30 pm

Advanced Container Technologies Inc. (ACTX) GrowPods Have Potential to Help Millions Living in Food-Insecure Households

Tens of millions of adults, children are living in food-insecure households Micro-farms, such as ACTX’s Grow Pods, are being evaluated as a potential solution for food insecurity With GrowPods, cultivation can be moved directly into the areas where food is needed An estimated 30 million adults and 12 million children are living in food-insecure households, reports a recent CNN Business article (https://cnw.fm/o1wn5). Those are people that Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of Grow Pods, believes it can help. “Families across America are precariously perched on the edge of a hunger cliff,” reports CNN Business. “With inflation on the…

Continue Reading

ThursdayJun 23, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants Licenses to Three Companies for the Month of June; Looks to Follow Through with its Scheduled 2022 Clinical Studies

Lexaria sold Premier Wellness Science Co. exclusive rights to use its patented DehyraTECH(TM) in Japan in a variety of CBD products Valcon Medical A/S also signed an agreement with Lexaria to use its platform for medical cannabis applications in Europe AnodGen Bioceuticals received a pharmaceutical license to use the platform for manufacturing and distributing CBD API powders in Europe, Australia, and New Zealand Lexaria Bioscience (NASDAQ: LEXX) kicked off the month by announcing an exclusive license to Premier Wellness Science Co. for the use of its patented DehydraTECH(TM) technology in Japan in a variety of CBD products. Announced on June…

Continue Reading

WednesdayJun 22, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Closes the First Half of 2022 with UK Product Launch, Successful Brand Acquisition, and a Collaboration with Ricky Williams’ Cannabis Brand, Highsman

Flora’s collaboration with Highsman seeks to elevate both Highsman and Vessel, Flora’s accessories brand, thereby inspiring greatness and creating an experience worth sharing The company’s acquisition of Masaya allows it to deliver on its promise to invest in safe, thorough, and cutting-edge cannabis research Flora’s product launch on Amazon.co.uk marks a big step in operations expansion in Europe The first half of 2022 has been successful for Flora Growth (NASDAQ: FLGC). At the beginning of the year, the company’s management noted how the cannabis sector was ripe for the picking. They noted how great brands and cost advantages are optimal…

Continue Reading

TuesdayJun 21, 2022 9:45 am

Expanding Array of API Enhancements Through Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented Drug Technology Bodes Well for New Patient Solutions

Drug bioavailability enhancement technology developer Lexaria Bioscience is working to increase the number of potential new solutions to unmet medical needs and improving existing treatments for other chronic conditions Lexaria’s patented DehydraTECH solution transforms a wide variety of orally and topically administered products into enhanced solutions that make the active pharmaceutical ingredients (“APIs”) more rapidly available and effective at lower doses  DehydraTECH-enhanced products have also demonstrated the ability to cross the blood-brain barrier through fatty acid transport proteins  The company’s ongoing series of tests of different DehydraTECH-enhanced products has led to a pre-IND filing with the FDA for a prospective…

Continue Reading

FridayJun 17, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Achieves Key Milestone in Global Expansion Plan with JustCBD Launch on Amazon UK

Flora Growth completed the acquisition of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, on February 28, 2022 The company then expanded its operational footprint in Europe and the UK in May 2022 to further its international growth strategy JustCBD products, including gummies and tinctures, will be available on www.Amazon.co.uk starting this month in a pilot-only program Flora Growth is optimistic that this launch will allow the company to reach a larger consumer base as it works towards further expanding its operations across Europe On February 28, 2022, Flora Growth (NASDAQ: FLGC) completed the…

Continue Reading

WednesdayJun 15, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Initiates Communication with the FDA Concerning Potential Treatment for Hypertension; Out-Licenses Its DehydraTECH Technology to International Markets

Lexaria, a global innovator of drug delivery platforms, recently filed a pre-IND meeting request letter with the FDA, initiating communication regarding the development of its DehydraTECH-CBD as a treatment for hypertension The company has been undertaking preparatory programs in readiness for the meeting, as well as an IND application filing The pre-IND meeting will confirm the details of the company’s IND-enabling program Lexaria also announced it had licensed its DehydraTECH technology to AnodGen, with the announcement following similar out-licensing agreements with Valcon Medical and Premier Science Early last September, global innovator Lexaria Bioscience (NASDAQ: LEXX) was pleased to announce it…

Continue Reading

MondayJun 13, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) and the Budding Alternative Nicotine Market

The nicotine pouch market is projected to reach $21.84 billion in 2027, up from $2.33 billion in 2020, representing a CAGR of 30.7% The smokeless tobacco products sector is expected to post a CAGR of 7.2% over the forecast period (2018-2025) Lexaria, through its patented DehydraTECH technology, is tapping into this important alternative nicotine sector  Its management is confident that its research and technology development investment will pay off and provide greater consumer satisfaction. In 2019, it was estimated that at least 1.1 billion people globally smoked cigarettes regularly. 780 million, representing 71% of the global smoking population, noted that…

Continue Reading

WednesdayJun 08, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Adding to Cannabis Product Line, Research

Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help…

Continue Reading

MondayJun 06, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets She will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programs Bell also participated in the first event in her new position- the Florida Industrial Hemp Conference and Exhibition held on May 20-22, 2022 In recent months, Flora Growth (NASDAQ: FLGC) has been on an aggressive international expansion plan that has seen exports to Mexico and Spain, with…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722